A. Montag and Associates »

Eterna Therapeutics shares owned by A. Montag and Associates

Quarter-by-quarter ownership of Eterna Therapeutics (ERNA) shares owned by A. Montag and Associates from 13F filings

Historical chart of A. Montag and Associates investment in Eterna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eterna Therapeutics held by A. Montag and Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eterna Therapeutics by A. Montag and Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $126 70 1.80
2023-09-30 $152 70 2.19
2023-06-30 $158 70 2.27
2023-03-31 $238 70 3.40
2022-12-31 $225 70 3.21

More positions owned by A. Montag and Associates

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Alphabet Cap Stk Cl C (GOOG)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Coca-Cola Company (KO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Rus 1000 Etf (IWB)
Home Depot (HD)
Amazon (AMZN)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core S&p Scp Etf (IJR)
Adobe Systems Incorporated (ADBE)

View all positions for A. Montag and Associates

Top funds holding Eterna Therapeutics

Cypress Point Wealth Management
Naviter Wealth
Sippican Capital Adivsors
CI Private Wealth
Vanguard Group
Baldwin Brothers
A. Montag and Associates
Royal Bank of Canada
Wells Fargo & Company
Citigroup
Jpmorgan Chase & Co
Nbc Securities
Aspire Private Capital

View all funds holding Eterna Therapeutics